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1. Introduction 
American trypanosomiasis, or Chagas disease, a zoonosis caused by Trypanosoma cruzi (T. 
cruzi), is endemic in Latin America and ten million people are estimated to be infected 
(Araújo et al 2009, World Health Organization (WHO), 2010). In the past decades, Chagas 
disease has been increasingly detected in other non-endemic countries such as Canada, the 
United States of America, Australia, Japan and in Europe. The presence of Chagas disease 
outside Latin America is the result of population mobility, notably migration, but also from 
travelers returning from Latin America and in adopted children (Schmunis, 2007). 
Subsequent transmission occurs through transfusion, transplantation or vertical routes. 
More than 10 000 deaths are estimated to occur annually from Chagas disease; its 
incapacitating effects and mortality are ones of the biggest public-health problems in Latin 
America. The 10-year mortality rate may range from 9% to 85%, depending on the extent of 
the cardiac damage induced by the parasite (WHO, 2010). 
Chagas disease manifests first with an acute phase, lasting for about 2 months, 
characterized by high parasitaemia. Most cases are asymptomatic or present nonspecific 
symptoms. Then, it turns into a chronic phase, the parasites hiding in target tissues, 
especially in the heart and digestive muscles (WHO, 2010) and in case of pregnancy, also 
in the placenta (Bittencourt, 1976). During the chronic phase, different clinical 
manifestations may be observed: 1) the cardiac form; 2) the digestive form, particularly 
enlargement of the esophagus and the colon; and 3) a mixed form (cardiac plus digestive) 
(Rassi, 2006). 
2. Congenital Chagas disease 
Congenital T. cruzi infection is associated with premature labor, low birth weight, and 
stillbirths (Altemani et al, 2000; Bittencourt, 1976; Shippey et al, 2005). Serologic prevalence 
among pregnant women may reach 80%, and rates of congenital infection vary from 1-21% 
(Blanco et al, 2000; Burgos et al, 2007; Kirchhoff, 1999; Shippey et al, 2005; Torrico et al, 
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2005). In Chile, in two of the endemic regions (IV and V regions), the congenital 
transmission rate of the parasite is 8.4% (Jercic et al, 2010). WHO/PAHO has considered that 
the number of infected woman at fertile age is of approximately 1.809.000 and that 14.400 
neonates are being infected at year (WHO, 2006). 
During congenital transmission, the parasite reaches the fetus by crossing the placental 
barrier (Carlier and Truyens, 2010; Duaso et al, 2010; Kemmerling et al, 2010). The fact that 
only a percentage of the infected mothers transmit parasites to their fetuses raises the 
question of the ability of the placenta as well as the immunological status of mother and 
fetus/newborn to impair the parasite transmission. Therefore, it is thought that congenital 
Chagas disease is product of a complex interaction between the parasite, the maternal and 
fetus/newborn immune responses and placental factors (Burgos et al, 2007; Kemmerling et 
al, 2010).  
2.1 The parasite 
T. cruzi is a haemophlagelated protozoan of the Kinetoplastida Order and Trypanosomatidae 
family (Chagas, 1909). The parasite biological cycle includes three cellular forms 
characterized by the relative positions of the flagellum, kinetoplast, and nucleus (Prata, 
2001): 1) Trypomastigotes: Approximately 20 µm in length and sub terminal kinetoplast. 
They constitute the non-replicative, mammalian infecting cellular form that is found in the 
blood and in the posterior intestine of triatomids. In mammals, this is the cellular form that 
disseminates infection through blood. 2) Epimastigotes: Also 20 µm in length with a 
kinetoplast anterior to the nucleus. They represent the multiplying parasite form in the 
triatomid intestine. 3) Amastigotes: Approximately 2 µm in diameter, rounded, with no 
emergent flagellum. It multiplies within the mammalian host cells, forming “nests”, until 
they rupture after several cell divisions. Before their release from the host cells, amastigotes 
differentiate into trypomastigotes that invade the blood stream; they may then enter any 
other nucleated cell. Epimastigotes can be grown in axenic cultures while amastigotes grow 
in cultured mammalian cells, releasing trypomastigotes that can be harvested to perform in 
vitro assays. 
T. cruzi display great biological, biochemical and genetic diversity, therefore different strains 
of the parasite have been identified and classified into six discrete typing units (DTU) 
(Telleria et al, 2010; Zingales et al, 2009). T. cruzi strains corresponding to different DTUs 
might have relevant consequences on congenital transmission and fetal/neonatal pathology. 
Nevertheless, different parasite strains identified in congenitally infected children 
correspond to the same strain identified in the mother, that is the predominantly T. cruzi 
lineage in the respective geographic region (Carlier and Truyens, 2010). There is no clear 
evidence that a relationship between T. cruzi strains and congenital infection in humans 
exists. Nevertheless, parasitaemia is associated with the risk of congenital transmission. 
Thus, a high parasitaemia, as in acute infection, correlates with a higher transmission rate 
(around 50%). In chronic infected patients, with very low parasitaemia, the transmission rate 
is between 1-21% (Brutus et al, 2010; Moretti et al, 2005). Though appearing a low rate of 
infection, chronically infected pregnant women represent a high risk of maintenance of 
Chagas disease both in endemic and non endemic areas.  
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2.2 Mother and fetus/newborn immune response 
The immune system is fundamental to protect the mother against the environment and to 
prevent damage to the fetus. During pregnancy the maternal immune system is 
characterized by a reinforced network of cellular and molecular recognition, 
communication, trafficking and repair; it raises the alarm to maintain the well-being of the 
mother and the fetus. On the other side, the fetus provides a developing active immune 
system that will modify the way the mother responds to the environment, providing a 
uniqueness of the immune system responses during pregnancy (Mor and Cardenas, 2010).  
A crucial factor to stop, limit, or permit the development of fetal/neonatal infection relates 
to the capacity of the mother and fetus/newborn to mount innate and/or specific immune 
response(s) against pathogens. Clinical studies have shown a strong association between 
intrauterine infections and pregnancy disorders such as abortion, preterm labor, intrauterine 
growth retardation and pre-eclampsia (Koga and Mor, 2010). As described above, congenital 
T. cruzi infection is associated with some of these pathologies (Altemani et al, 2000; 
Bittencourt, 1976; Carlier and Truyens, 2010; Shippey et al, 2005).  
Production of pro-inflammatory cytokines can be observed in uninfected babies born to 
infected mothers (Carlier and Truyens, 2010). Contrarily, the levels of inflammation markers 
and activation of NK cells are rather low in congenitally infected newborns (Hermann et al, 
2010). These data highly suggest a protective role of such innate defenses in an uninfected 
newborn from infected mothers. On the other side, maternal T. cruzi-specific IgG antibodies 
play protective roles in mothers and in fetuses when antibodies are transferred through the 
placenta (Breniere et al, 1983) and also may contribute to a reduction in parasitaemia 
(Carlier and Truyens, 2010). 
2.3 Placenta 
The placenta is the principal site for the exchange of nutrients and gases between the mother 
and fetus. This organ plays an important role in hormone, peptide, and steroid synthesis 
necessary for a successful pregnancy (Moore and Perseaud, 2004). The human placenta is 
classified as a hemochorial villous placenta in which the free chorionic villi, formed by the 
trophoblast and the villous stroma, are the functional units. The trophoblast contacts 
maternal blood in the intervillous space and is separated by a basal lamina from the villous 
stroma, which is connective tissue containing the vascular endothelium, fibroblasts and 
macrophages (Berniscke et al, 2006). Trophoblast, basal laminae and villous stroma with the 
endothelium of fetal capillaries form the placental barrier that must be crossed by different 
pathogens, including T. cruzi, to infect the fetus during vertical transmission (Carlier and 
Truyens, 2010; Duaso et al, 2010; Kemmerling et al, 2010) (Figure 1). 
Placentas from mother with acute Chagas disease (high parasitaemia) show severe 
histopathological changes, such as extensive necrosis, inflammatory infiltrate and 
amastigote nests (Altemani et al, 2000). Contrarily, placentas from mother with chronic 
Chagas disease do not present necrotic foci and inflammatory infiltrate. Although parasite 
antigens can be visualized in the villous stroma, the typical amastigote nests are not present 
(Duaso et al, 2011b). In accordance with these results, in ex vivo infected placental explants 
although parasite antigens and DNA can be detected (Al Khan et al, 2011; Duaso et al, 2010; 
Luján et al, 2004), amastigote nests are not observed. Only few individual parasites can be 
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detected. These evidences suggest that anti-parasite mechanisms may exist in the placental 
tissue of women suffering chronic Chagas disease. 
 
The placental barrier is composed of syncytiotrophoblast (ST) with ST knots, cytotrophoblast (CT), fetal 
connective tissue of the villous stroma, fetal capillary and basal lamina between villous stroma and 
trophoblast as well as around fetal endothelium. 
Fig. 1. Human placental barrier 
3. Trypanosoma cruzi interaction with the trophoblast 
The major constituent of the human placenta is the trophoblast, the first cell lineage that 
develops before any embryonic tissue arises. Between morula and blastocyst stages, the 
trophoblast lineage forms a cover around the early embryo (the embryoblast) (Berniscke et 
al, 2006; Huppertz and Borges, 2008). The human trophoblast differentiates into two major 
subtypes (Drewlo et al, 2008; Huppertz and Gauster, 2010; Huppertz and Borges, 2008): a) 
Cells that invade maternal uterine tissue and differentiate into the extravillous trophoblast, 
and b) Cells that remain within the placenta and differentiate into the villous trophoblast 
forming the epithelial cover of the placental villi and constituting part of the placental 
barrier (Berniscke et al, 2006; Kemmerling et al, 2010) (see Figure 1). The villous trophoblast is 
composed of two cellular layers: the syncytiotrophoblast (ST) and the cytotrophoblast (CT). The 
CT displays high proliferative properties, whereas the differentiated ST loses its generative 
capacity and is no longer able to proliferate. The ST is a multinucleated layer that forms the 
outer surface of placental villi and comes into direct contact with maternal blood (Berniscke 
et al, 2006; Huppertz and Borges, 2008). This cell layer is a typical syncytium with plasma 
membranes only on the apical and basal sides. The ST is continuous and normally 
uninterrupted, covering all villous trees of the human placenta. It is generated and 
maintained through syncytial fusion by incorporation of CT cells (Berniscke et al, 2006; 
Huppertz, 2010). 
During congenital infection the first fetal cells exposed to the parasite are those of the 
syncytiotrophoblast. In human chorionic villi infected ex vivo the parasite induces 
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detachment and destruction of this tissue layer (Duaso et al, 2010). Other pathogen like 
cytomegalovirus (Chan and Gilbert, 2006), Plasmodium falciparum (Maubert et al, 1997) and 
Toxoplasma gondii (Abbasi et al, 2003) also induce syncytiotrophoblast damage.  
The trophoblast, as covering epithelia, forms a physical barrier to pathogens. On the other 
hand, the epithelial turnover has been considered part of the innate immune system 
(Janeway and Traver, 2004) due to the fact that pathogens, prior to cell invasion, must attach 
to the surface of cells. As these cells are continuously eliminated, the attached pathogens are 
removed with them.  
Trophoblast turnover: Trophoblast turnover implies precise orchestration of different cellular 
processes that include cell proliferation of the CT, differentiation (meaning the syncytial 
fusion by incorporating CT cells into a non replicative ST and differentiation of CT cells 
previous fusion with the ST) and cell death (Berniscke et al, 2006; Huppertz, 2010). Cell 
death in the trophoblast manifests by formation of apoptotic ST knots which are released 
into the maternal blood. The apoptotic knots counterbalance the continuous incorporation of 
CT cell into the ST (Berniscke et al, 2006).  
Cell proliferation: As previously reviewed and described above, cells of the CT are the only 
ones showing capacity for cell proliferation (Berniscke et al, 2006). Importantly, growth, 
expansion and maintenance of the ST throughout pregnancy depend mainly on the 
continuous incorporation of CT cells into the ST (Berniscke et al, 2006; Huppertz, 2010). 
Therefore cell proliferation of CT is fundamental for the trophoblast turnover in health and 
disease. We identified an increase in cell proliferation in the CT upon infection of villous 
explants with T. cruzi, particularly in cells beneath the areas where the ST is detached and 
destroyed (Figure 2).  
Cell differentiation in the trophoblast: Trophoblast fusion is dependent on and regulated by 
multiple factors such as fusion proteins, proteases and cytoskeletal proteins as well as 
cytokines, hormones and transcription factors (Huppertz 2010; Huppertz and Gauster, 
2011). Some of these factors, considered as trophoblast “differentiation markers” or “fusion 
markers”, are the following: 
a. Syncytin family proteins: Syncytins are fusogenic proteins encoded by envelope genes 
(env genes) of the human endogenous retrovirus (HERV)-W (Syncytin-1), (HERV)-FRD 
(Syncytin-2), and (HERV)-P(b) (Syncytin-3;) (Ruebner et al, 2010). HERVs contribute to 
genome plasticity, protect the host against infection with related pathogenic and 
exogenous retroviruses, and play a vital role in the development of the placenta (Black 
et al, 2010). Knock down of syncytin-1 inhibited syncytialization of primary 
trophoblasts (Gauster et al, 2009).  
b. Transcription factors: Glial cell missing-1 (GCM1), a placenta-specific transcription factor, 
regulates transcription via two GCM1 binding sites upstream the 5′-long terminal 
repeat of the syncytin-1 gene (Huppertz and Borges, 2008; Yu et al, 2002). GCM1 is 
expressed in highly differentiated CT cells (Baczyk et al, 2004; Huppertz and Borges, 
2008).  
c. Other membrane proteins: Presence of gap junctions is considered as a prerequisite for 
trophoblast syncytialization (Gauster et al, 2009). Inhibition of connexin 34 expression 
by antisense techniques impairs cell fusion in primary trophoblast cultures (Frendo et 
al, 2003).  
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Human chorionic villi incubated with 1 x 105 trypomastigotes DM28c strain for 24 hours (B) show 
increase in PCNA immunoreactivity compared to control tissue (A). In control (A, arrow) and ex vivo 
infected chorionic villi (B, arrows) PCNA immunoreactivity can be observed. Note that PCNA 
immunoreactivity is increased in cells beneath syncythiotrophoblast detachment (arrows). Chorionic 
villi were processed for routine immunohistochemistry and Antigen-Antibody complex was stained 
with DAB. Bar scale: 20 µm. 
In (C) upper panel a representative western blot for PCNA detection is shown. The bar graphs under 
the Western blots represent the ratios, normalized with respect to control values, of PCNA over 
GAPDH. Values represents means ±SD, p≤0.5, n=3.  
Fig. 2. T. cruzi induces cell proliferation in the trophoblast 
Cell differentiation and apoptosis: In the trophoblast, cell differentiation and apoptotic cell 
death are closely related (Huppertz and Gauster, 2010). While seemingly paradoxical, there 
are strong evidences that initiator caspases, especially caspase-8, are involved not only in 
apoptosis but in differentiation processes in diverse cell types and tissues. Some examples 
are the enucleation processes during terminal differentiation of erythrocytes (Carlile et al, 
2004) and keratinocytes (Denecker et al, 2008) as well as other differentiation processes such 
as monocytes into macrophages (Sordet et al, 2002) or formation of myotubes in striated 
skeletal muscle tissue (Fernando et al, 2002).  
Programmed cell death in the trophoblast presents most, but not all, of the classic features of 
apoptosis (Bernischke, 2006; Huppertz and Gauster, 2010). The most remarkable difference 
between “classic apoptosis” and “trophoblast apoptosis” is that the latter is a prolonged 
form of apoptosis (3-4 weeks) (Bernischke, 2006). The following data suggests that this 
prolonged form of apoptosis drives, at least partially, the stages of trophoblast 
differentiation and turnover:  
a. Initiation stages of apoptosis are responsible for the CT cell exit from the cell cycle and 
for its entrance into the differentiation pathway (Bernischke, 2006; Huppertz et al, 2002). 
The matador/Bcl-2 ovarian killer (Mtd/Bok) regulates human trophoblast apoptosis 
and proliferation. The main isoform of Mtd/Bok associated with trophoblast 
proliferation is Mtd-L, the full-length isoform, which preferentially is localized in the 
nuclear compartment in proliferating cells, whereas during apoptosis it switched 
localization to the cytoplasm where it is associated with mitochondria. Mtd-L 
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expression in proliferating cells co-localized with cyclin E1, a G1/S phase cell cycle 
regulator (Ray et al, 2010).  
b. Caspase 8 is activated in highly differentiated CT just prior to fusion and escorts the 
fusing cell content including the nucleus into the ST; interestingly, it has not been found 
in proliferating CT cells (Black et al, 2010; Huppertz and Gauster, 2010; Huppertz and 
Borges, 2008). 
c. Activation of caspase-8 induces phosphatidylserine “flip”, which is a key signal for 
syncytial fusion (Huppertz and Gauster, 2010; Huppertz and Gauster, 2011) and for cell 
death by apoptosis (Savill, 1998). Highly differentiated CT cells display the flip of 
phosphatidylserine without any signs of apoptosis (Huppertz et al, 1998; Rote et al, 
2010). Furthermore, it has been demonstrated that the phosphatidylserine flip is also 
required for fusion of trophoblast-derived BeWo choriocarcinoma cells (Lyden et al, 
1993).  
d. Caspase-8 is responsible for cytoskeleton rearrangement previous to cell fusion (Rote el 
al, 2010) by cleaving ǂ-fodrin (Huppertz and Gauster, 2011). ǂ-fodrin belongs to the 
spectrin protein family of sub-membranous cytoskeletal proteins that carry binding 
sites for phosphatidylserine. The spectrin network maintains the curvature of the 
plasma membrane and its degradation affects membrane curvature facilitating fusion 
(Martens and McMahon, 2008). The expression of ǂ-fodrin is diminished in highly 
differentiated CT and is entirely missing in the ST (Huppertz and Gauster, 2011).  
e. Upon syncytial fusion, excess expression of apoptosis inhibitors like bcl-2 and mcl-1 
blocks further progression of the apoptosis cascade for 3 to 4 weeks (Bernischke, 2006; 
Huppertz et al, 1998; Huppertz and Gauster, 2011).  
Interestingly, diverse pathogens, including T. cruzi, induce apoptosis in the placenta, 
especially in the trophoblast (Duaso et al, 2011a).  
Regulation of trophoblast differentiation: Cytokines and growth factors derived from the 
maternal and fetal environment are involved in regulating trophoblast turnover (Gauster et 
al, 2009). Epidermal growth factor (EGF) (Morrish et al, 1987), colony-stimulating factor 
(CSF) (Garcia-Lloret et al, 1994), granulocyte-macrophage colony stimulating factor (GM–
CSF), leukemia-inhibitory factor (LIF) (Yang et al, 2003), transforming growth factor (TGF)-ǂ 
and vascular endothelial growth factor (VEGF) (Crocker et al, 2001; Gauster et al, 2009) 
induce syncytialization of CT and secretion of human chorionic gonadotropin (hCG) as well 
as of human placental lactogen (hPL). Interestingly, hCG secreted by the ST can act in an 
autocrine manner to increase syncytium formation (Shi et al, 1993; Yang et al, 2003). The 
secretion of hCG and hPL are the main biochemical markers of trophoblast differentiation in 
vitro (Drewlo et al, 2008). In contrast, tumor necrosis factor (TNF)-a (Leisser et al, 2006) as 
well as transforming growth factor (TGF)-ǃ impaired syncytium formation in chorionic villi 
explants in vitro and inhibited secretion of hCG and hPL (Morrish et al, 1987; Huppertz and 
Gauster, 2011).  
Trophoblast and inflammatory response: Expression of all 10 described TLRs, as well as of 
various co-receptors and accessory proteins, has been described in the human placenta 
(Koga and Mor, 2010). TLRs 1-2 and 4-6 are membrane receptors while TLRs 3 and 9 are 
cytoplasmic receptors and recognize extracellular and intracellular signals, respectively. 
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Following ligation, the majority of TLRs recruit the intracellular signaling adapter protein, 
myeloid differentiation factor 88 (MyD88), leading to a subsequent kinase cascade, which 
triggers the activation of NFκB pathway, with resultant generation of an inflammatory 
response. TLR3 and TLR4 can also signal in a MyD88-independent manner (Yamamoto et al, 
2003). This signaling occurs through an adapter protein Toll/IL-1 receptor domain-
containing adaptor inducing IFN-b (TRIF), which not only activates the NFκB pathway, but 
also results in the phosphorylation of IFN regulatory factor-3 (IRF-3). This alternative 
pathway generates a response associated with the production of type I IFNs and IFN-
inducible genes (Hemmi et al, 2000; Koga and Mor, 2010). The expression of TLR varies 
during pregnancy, but TLR-2, TLR-4 (Ma et al, 2006) as well as TLR 9 (Komine-Aizawa, 
2008) are expressed in human term placenta and recognize T. cruzi. The principal T. cruzi 
mediated TLR activation is induced by members of GPI-anchored mucins located on T. cruzi 
trypomastigote surface that activates TLR-2 and by CpG-rich parasite DNA that activates 
TLR-9 (DosReis, 2011; Tarleton, 2007). The most important cytokines secreted after TLR-2, -4 
and -9 activation are IL-1ǂ, IL-6, IL-8 and TNF-ǂ. TLR-4 also mediates the production of 
IFN-ǃ (Koga and Mor, 2010). Interestingly, activation of TLR-2 also induces activation of 
caspase 8 (Abrahams and Mor, 2005), an enzyme that is fundamental in apoptotic cell death 
as well as in trophoblast differentiation (see above).  
4. Trypanosoma cruzi interaction with the villous stroma 
To reach fetal capillaries, the parasite must cross the villous stroma. The villous stroma is a 
connective tissue that contains mesenchymal cells, fibroblasts and macrophages inserted in 
the extracellular matrix (ECM).  
T. cruzi invades preferentially macrophages and fibroblasts, both present in the villous 
stroma. However, during tissue invasion the parasite not only must internalize into the cells 
but also have to deal with the ECM. 
The basal lamina, a specialized structure of ECM molecules located between trophoblast and 
the fetal connective tissue, is one barrier that the parasite must cross. T. cruzi presents 
surface molecules, such as gp85 (Marino et al, 2003) and gp83 (Nde et al, 2006) glycoproteins 
that bind to laminin and fibronectin (Marino et al, 2003; Nde et al, 2006) and to sulfated 
glycosamineglicans such as heparan sulphate (Lima et al, 2002). We have previously shown 
that the parasite induces a decrease of glycosylated molecules of the basal lamina, 
specifically laminin and heparan sulphate (Duaso et al, 2010; Duaso et al 2011b).  
Collagen IV, other basal lamina components, is also destroyed by the parasite, as evidenced 
by the decrease in the immunoreactivity of this macromolecule. The decrease in 
immunoreactivity could also be explained by a change in the epitope as a result of this 
binding. Interestingly, fibronectin, another principal basal lamina component, is not altered 
during ex vivo infection. The selective destruction of the basal lamina could be part of the 
mechanism of connective tissue invasion, after an effective epithelial infection.  
Basal lamina is also present between the fetal endothelium and the connective tissue. This 
basal lamina is the last barrier that any pathogen should cross to reach fetal circulation. As 
expected, T. cruzi trypomastigotes induce a similar decrease of laminin and heparan 
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sulphate in the basal lamina located around the fetal capillaries, as compared to that 
observed in the basal lamina beneath the trophoblast (Duaso et al, 2010).  
Collagen IV is an exception to this since no change is observed. Possibly, the destruction 
of collagen IV around fetal endothelium is not necessary for the parasite invasion of fetal 
capillaries or occurs at a later time (Duaso et al, 2010). In other studies, an increase of 
laminin expression in cardiac tissue has been reported (Scharfstein and Morrot, 1999; 
Marino et al, 2003). The increase of laminin expression could be induced by the parasite, 
which needs to attach to ECM molecules for cellular invasion (Marino et al, 2003). The 
silencing of the laminin gene inhibits cell invasion of the T. cruzi (Nde et al, 2006). The 
parasitic protease cruzipain degrades collagen IV and fibronectin, exposing epitopes to 
which T. cruzi binds (Scharfstein and Morrot, 1999), facilitating also the binding to laminin 
and consequently the cell invasion. On the other hand, the breakdown of the ECM 
facilitates the penetration of the parasite through basal lamina and connective tissue of 
villous stroma. 
Between the trophoblast and fetal capillaries, the fetal connective tissue is another important 
barrier for the parasite. Ex vivo infection of human chorionic villi induces a severe collagen I 
disorganization as seen by Picrosirius red-hematoxylin staining (Duaso et al, 2010). The 
same effect can be observed in placentas from woman with chronic Chagas disease (Duaso 
et al, 2011b). The collagen I degradation is probably due to the presence of cruzipain that 
degrades this type of ECM component (Scharfstein and Morrot, 1999). In other tissue, 
specifically the lamina propria of seminiferous tubules in mice, T. cruzi infection also 
induces collagen I disorganization (Carvalho et al, 2009). Other enzymes which may 
participate in collagen I destruction are the metalloproteinases MMP-2 and MMP-9. These 
proteases are induced by T. cruzi in the myocardium of mice with acute Chagas´disease; and 
its inhibition reduces myocarditis and improves survival during the acute phase of infection 
(Gutiérrez et al, 2008). Preliminary studies of our laboratory indicates that the parasite 
increase the activity of the MMP-2 and MMP-9. Collagen I constitute a basic component of 
the tri-dimensional network of ECM, formed by different types of collagen and elastic fibers, 
proteoglycans and glycoproteins. If the “basic skeleton” of the ECM is destroyed, the normal 
conformation of ECM is disorganized, a condition which may facilitate the mobilization of 
the parasite inside the tissue to its target. Additionally, it has been proposed that ECM 
alterations produced by the parasite’s presence not only promote its motility in tissues and 
its entrance into cells, but also alter the presence of cytokines and chemokines, which in turn 
permits T. cruzi to modulate and escape both the inflammatory response and the immune 
response (Marino et al, 2003; Duaso et al, 2010; Duaso et al, 2011b).  
5. Conclusion  
T. cruzi induces trophoblast destruction and detachment, selective disorganization of the 
basal lamina and of collagen I in the connective tissue of villous stroma and apoptosis in the 
chorionic villi. These results suggest that the penetration of this parasite in the placenta is a 
consequence of its proteolytic activity on the basal lamina and on the connective tissue. 
Together with the induction of apoptosis these may be part of the mechanisms of infection 
and tissue invasion by this parasite. 
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